Strategic approaches to drug design. II. Modelling studies on phosphodiesterase substrates and inhibitors (Q69843559)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

title

Strategic approaches to drug design. II. Modelling studies on phosphodiesterase substrates and inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

author name string

A Davis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

B H Warrington

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

J G Vinter

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

publication date

1 July 1987

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

Journal of Computer - Aided Molecular Design

6 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

page(s)

97-119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01676955

6 October 2019

exact match

0 references

cites work

Bipyridine cardiotonics: the three-dimensional structures of amrinone and milrinone

1 reference

12 December 2020

A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity

1 reference

12 December 2020

Complementary base pairing and the origin of substitution mutations

1 reference

12 December 2020

Selective inhibition of cyclic nucleotide phosphodiesterases by analogs of 1-methyl-3-isobutylxanthine

1 reference

12 December 2020

Determination of the syn-anti Equilibrium of Some Purine 3':5'-Nucleotides by Nuclear-Magnetic-Relaxation Perturbation in the Presence of a Lanthanide-Ion Probe

1 reference

12 December 2020

Cardiotonic agents. 4. Synthesis and biological evaluation of N-substituted 2,4,4a,5-tetrahydro-3H-indeno[1,2-c]pyridazin-3-ones: rigid structures derived from CI-930 and analogues

1 reference

12 December 2020

Identification and properties of cyclic nucleotide phosphodiesterases

1 reference

12 December 2020

The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle. Implications for the mechanism of action of selective phosphodiesterase inhibitors

1 reference

12 December 2020

Conformations of cyclic 3',5'-nucleotides. Effect of the base on the synanti conformer distribution

1 reference

12 December 2020

Activating effects of AR-L 115 BS on the Ca2+ sensitive force, stiffness and unloaded shortening velocity (Vmax) in isolated contractile structures from mammalian heart muscle

1 reference

12 December 2020

The molecular structure of the free acid of guanosine 3',5'-cyclic monophosphate (cyclic GMP)

1 reference

12 December 2020

Carbon-13 magnetic resonance. XXVI. Quantitative determination of the tautomeric populations of certain purines

1 reference

12 December 2020

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 reference

12 December 2020

Functional group contributions to drug-receptor interactions.

1 reference

12 December 2020

Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents

1 reference

12 December 2020

Strategic approaches to drug design. I. An integrated software framework for molecular modelling.

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01676955

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2848100%20AND%20SRC:MED&resulttype=core&format=json

6 October 2019

DBLP publication ID

journals/jcamd/DavisWV87

1 reference

DBLP Dataset 2021-01-02

28 January 2021

1 reference